Reduced severe infection risk with avacopan in ANCA-associated vasculitis: a multicentre REVEAL cohort with time-varying exposure modelling.

Yoshida T, Hiwa R, Shoji M, Manabe A, Kadoba K, Taniguchi T, Tsuge R, Matsuda S, Kotani T, Okazaki A, Masuda Y, Hatta M, Shiomi M, Ito N, Fujiki Y, Miyake H, Watanabe R, Hashimoto M, Morinobu A

Open source

DOI
10.1093/rheumatology/keag517
Published
2026 Sep 17
Container
Rheumatology (Oxford, England)
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/rheumatology/keag517,
  title = {Reduced severe infection risk with avacopan in ANCA-associated vasculitis: a multicentre REVEAL cohort with time-varying exposure modelling.},
  author = {Yoshida T and Hiwa R and Shoji M and Manabe A and Kadoba K and Taniguchi T and Tsuge R and Matsuda S and Kotani T and Okazaki A and Masuda Y and Hatta M and Shiomi M and Ito N and Fujiki Y and Miyake H and Watanabe R and Hashimoto M and Morinobu A},
  year = {2026},
  journal = {Rheumatology (Oxford, England)},
  doi = {10.1093/rheumatology/keag517},
  url = {https://doi.org/10.1093/rheumatology/keag517}
}

RIS

TY  - JOUR
TI  - Reduced severe infection risk with avacopan in ANCA-associated vasculitis: a multicentre REVEAL cohort with time-varying exposure modelling.
AU  - Yoshida T
AU  - Hiwa R
AU  - Shoji M
AU  - Manabe A
AU  - Kadoba K
AU  - Taniguchi T
AU  - Tsuge R
AU  - Matsuda S
AU  - Kotani T
AU  - Okazaki A
AU  - Masuda Y
AU  - Hatta M
AU  - Shiomi M
AU  - Ito N
AU  - Fujiki Y
AU  - Miyake H
AU  - Watanabe R
AU  - Hashimoto M
AU  - Morinobu A
PY  - 2026
JO  - Rheumatology (Oxford, England)
DO  - 10.1093/rheumatology/keag517
UR  - https://doi.org/10.1093/rheumatology/keag517
ER  - 

APA

T, Y., R, H., M, S., A, M., K, K., T, T., R, T., S, M., T, K., A, O., Y, M., M, H., M, S., N, I., Y, F., H, M., R, W., M, H., & A, M. (2026). Reduced severe infection risk with avacopan in ANCA-associated vasculitis: a multicentre REVEAL cohort with time-varying exposure modelling.. Rheumatology (Oxford, England). https://doi.org/10.1093/rheumatology/keag517

Source records